Michael Yang is a Pioneer at Artis Ventures. Currently he serves as the President and CEO of ViaCyte, an AV3 Portfolio Company. Prior to ACADIA, Yang served as the CCO at ACADIA Pharmaceuticals and the President of Immunology and CNS divisions at Janssen Pharmaceuticals. As a Pioneer, Michael brings 30+ years in the pharmaceutical industry with expertise in drug development, marketing, and sales.

Michael Yang